[6-K] Dr. Reddy's Laboratories Limited American Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Erie Indemnity Co. (ERIE) EVP, Secretary & General Counsel Brian W. Bolash filed a Form 4 covering activity on 22 Jul 2025.

• Non-derivative: Form shows a disposition of 445 Class A shares; no transaction price was reported.
• Derivative: Bolash acquired 11.619 share credits in the Incentive Compensation Deferral Plan via dividend reinvestment at an implied $364.10 per credit. Post-transaction, he holds 3,110.869 share credits.
• The share-credit units represent the right to receive an equal number of Class A shares upon retirement or other separation; they have no expiration or exercise date.

The reported transactions are routine, small relative to ERIE’s float and market cap, and do not alter the executive’s control or governance position. No open-market purchases or sales were disclosed.

Insights

Financial Analyst

TL;DR: Minor insider activity—445 shares sold, 11.6 share credits added; negligible impact on valuation or insider-sentiment signals.

The filing combines an automatic dividend reinvestment under ERIE’s deferred-comp plan with a small disposition of Class A shares. The net cash outlay is minimal, and the 445-share sale represents an immaterial fraction of daily volume and insider holdings. Because the derivative credits are non-tradable until separation, they do not reflect an active bullish stance. Overall insider ownership and governance rights remain unchanged, suggesting neutral fundamental impact.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

July, 2025

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x                         Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨                         No x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated July 23, 2025

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: July 23, 2025	By:	/s/ K Randhir Singh
		Name: K Randhir Singh
		Title:   Company Secretary

3